Medicine and Dentistry
Adjuvant Chemotherapy
16%
Bladder
16%
Bladder Cancer
100%
Cancer
16%
Cystectomy
100%
Disease Specific Survival
66%
Hazard Ratio
66%
Lymph Node
66%
Lymph Node Metastasis
16%
Multivariate Analysis
33%
Pelvis Lymphadenectomy
16%
Prognostic Factor
50%
Prospective Study
16%
Recurrence Free Survival
66%
Survival Rate
16%
Transitional Cell Carcinoma
16%
Keyphrases
Adjuvant Chemotherapy
8%
Bladder Cancer
100%
Consecutive Patients
8%
Contradictory Results
8%
Disease-specific Survival
33%
Extranodal Extension
100%
Hazard Ratio
33%
Histological Examination
8%
Independent Prognostic Factor
16%
Lymph Node Metastasis
8%
Lymph Node Ratio
16%
Multivariate Analysis
16%
Nodal Status
8%
Node-positive
100%
Pelvic Lymphadenectomy
8%
Positive Lymph Nodes
16%
Prognostic Factors
8%
Prognostic Information
8%
Prognostic Role
8%
Radical Cystectomy
50%
Recurrence Prediction
8%
Recurrence-free Survival
33%
Significant Predictors
8%
Tertiary Hospital
8%
Upper Tract Urothelial Carcinoma
8%
Urological Malignancies
8%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Chemotherapy
16%
Disease Specific Survival
66%
Lymph Node Metastasis
16%
Prospective Study
16%
Recurrence Free Survival
66%
Survival Rate
16%
Transitional Cell Carcinoma
16%